UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
{
"resourceType" : "Bundle",
"id" : "CefStragen-250mg-Powder-SE-IS-MPD-BBDL",
"type" : "collection",
"entry" : [
{
"fullUrl" : "https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/MedicinalProductDefinition/CefStragen-250mg-Powder-SE-IS-MPD",
"resource" : {
"resourceType" : "MedicinalProductDefinition",
"id" : "CefStragen-250mg-Powder-SE-IS-MPD",
"meta" : {
"profile" : [
🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLMedicinalProductDefinition"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"MedicinalProductDefinition_CefStragen-250mg-Powder-SE-IS-MPD\"> </a><p class=\"res-header-id\"><b>Generated Narrative: MedicinalProductDefinition CefStragen-250mg-Powder-SE-IS-MPD</b></p><a name=\"CefStragen-250mg-Powder-SE-IS-MPD\"> </a><a name=\"hcCefStragen-250mg-Powder-SE-IS-MPD\"> </a><a name=\"hcCefStragen-250mg-Powder-SE-IS-MPD-en-US\"> </a><p><b>identifier</b>: <code>http://ema.europa.eu/fhir/mpId</code>/SE-100002835-00021952, <code>http://ema.europa.eu/fhir/eurdId</code>/615</p><p><b>domain</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000000004 100000000012}\">Human use</span></p><p><b>status</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/200000005003 200000005004}\">Current</span></p><p><b>combinedPharmaceuticalDoseForm</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/200000000004 100000073866}\">Powder for solution for injection</span></p><p><b>indication</b>: </p><div><p>Cefuroxim Stragen är avsett för behandling av nedanstående infektioner hos vuxna och barn, även nyfödda (från födelsen). • Samhällsförvärvad pneumoni • Akut exacerbation av kronisk bronkit. • Komplicerade urinvägsinfektioner, även pyelonefrit. • Mjukdelsinfektioner: cellulit, erysipelas och sårinfektioner. • Intraabdominella infektioner. • Profylax mot infektion inför gastrointestinal (även esofageal), ortopedisk, kardiovaskulär och gynekologisk operation (även kejsarsnitt). Vid behandling och förebyggande av infektioner då det är mycket troligt att anaeroba organismer påträffas ska cefuroxim administreras tillsammans med ett lämpligt antianaerobt antibiotikum. Hänsyn ska tas till officiella riktlinjer om lämplig användning av antibakteriella medel.</p>\n</div><p><b>legalStatusOfSupply</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000072051 100000072084}\">Medicinal product subject to medical prescription</span></p><p><b>classification</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000116677 100000093533}\">J01DC02</span></p><blockquote><p><b>name</b></p><p><b>productName</b>: Cefuroxim Stragen 250 mg Pulver till injektionsvätska, lösning</p><blockquote><p><b>part</b></p><p><b>part</b>: Cefuroxim Stragen</p><p><b>type</b>: <span title=\"Codes:{http://spor.ema.europa.eu/v1/lists/220000000000 220000000002}\">Invented name part</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: 250 mg</p><p><b>type</b>: <span title=\"Codes:{http://spor.ema.europa.eu/v1/lists/220000000000 220000000004}\">Strength part</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: pulver till injektionsvätska, lösning</p><p><b>type</b>: <span title=\"Codes:{http://spor.ema.europa.eu/v1/lists/220000000000 220000000005}\">Pharmaceutical dose form part</span></p></blockquote><h3>Usages</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Country</b></td><td><b>Language</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000000002 100000000535}\">Kingdom of Sweden</span></td><td><span title=\"Codes:{urn:ietf:bcp:47 sv}\">Swedish</span></td></tr></table></blockquote></div>"
},
"identifier" : [
{
"system" : "http://ema.europa.eu/fhir/mpId",
"value" : "SE-100002835-00021952"
},
{
"system" : "http://ema.europa.eu/fhir/eurdId",
"value" : "615"
}
],
"domain" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000000004",
"code" : "100000000012",
"display" : "Human use"
}
]
},
"status" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/200000005003",
"code" : "200000005004",
"display" : "Current"
}
]
},
"combinedPharmaceuticalDoseForm" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/200000000004",
"code" : "100000073866",
"display" : "Powder for solution for injection"
}
]
},
"indication" : "Cefuroxim Stragen är avsett för behandling av nedanstående infektioner hos vuxna och barn, även nyfödda (från födelsen). • Samhällsförvärvad pneumoni • Akut exacerbation av kronisk bronkit. • Komplicerade urinvägsinfektioner, även pyelonefrit. • Mjukdelsinfektioner: cellulit, erysipelas och sårinfektioner. • Intraabdominella infektioner. • Profylax mot infektion inför gastrointestinal (även esofageal), ortopedisk, kardiovaskulär och gynekologisk operation (även kejsarsnitt). Vid behandling och förebyggande av infektioner då det är mycket troligt att anaeroba organismer påträffas ska cefuroxim administreras tillsammans med ett lämpligt antianaerobt antibiotikum. Hänsyn ska tas till officiella riktlinjer om lämplig användning av antibakteriella medel.",
"legalStatusOfSupply" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000072051",
"code" : "100000072084",
"display" : "Medicinal product subject to medical prescription"
}
]
},
"classification" : [
{
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000116677",
"code" : "100000093533",
"display" : "J01DC02"
}
]
}
],
"name" : [
{
"productName" : "Cefuroxim Stragen 250 mg Pulver till injektionsvätska, lösning",
"part" : [
{
"part" : "Cefuroxim Stragen",
"type" : {
"coding" : [
{
"system" : "http://spor.ema.europa.eu/v1/lists/220000000000",
"code" : "220000000002",
"display" : "Invented name part"
}
]
}
},
{
"part" : "250 mg",
"type" : {
"coding" : [
{
"system" : "http://spor.ema.europa.eu/v1/lists/220000000000",
"code" : "220000000004",
"display" : "Strength part"
}
]
}
},
{
"part" : "pulver till injektionsvätska, lösning",
"type" : {
"coding" : [
{
"system" : "http://spor.ema.europa.eu/v1/lists/220000000000",
"code" : "220000000005",
"display" : "Pharmaceutical dose form part"
}
]
}
}
],
"usage" : [
{
"country" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000000002",
"code" : "100000000535",
"display" : "Kingdom of Sweden"
}
]
},
"language" : {
"coding" : [
{
"system" : "urn:ietf:bcp:47",
"code" : "sv",
"display" : "Swedish"
}
]
}
}
]
}
]
}
},
{
"fullUrl" : "https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/RegulatedAuthorization/CefStragen-250mg-Powder-SE-IS-RA",
"resource" : {
"resourceType" : "RegulatedAuthorization",
"id" : "CefStragen-250mg-Powder-SE-IS-RA",
"meta" : {
"profile" : [
🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLRegulatedAuthorization"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"RegulatedAuthorization_CefStragen-250mg-Powder-SE-IS-RA\"> </a><p class=\"res-header-id\"><b>Generated Narrative: RegulatedAuthorization CefStragen-250mg-Powder-SE-IS-RA</b></p><a name=\"CefStragen-250mg-Powder-SE-IS-RA\"> </a><a name=\"hcCefStragen-250mg-Powder-SE-IS-RA\"> </a><a name=\"hcCefStragen-250mg-Powder-SE-IS-RA-en-US\"> </a><p><b>identifier</b>: <code>http://ema.europa.eu/fhir/marketingAuthorizationNumber</code>/21952</p><p><b>subject</b>: <a href=\"MedicinalProductDefinition-CefStragen-250mg-Powder-SE-IS-MPD.html\">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100002835-00021952,http://ema.europa.eu/fhir/eurdId#615; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Powder for solution for injection; indication = Cefuroxim Stragen är avsett för behandling av nedanstående infektioner hos vuxna och barn, även nyfödda (från födelsen). • Samhällsförvärvad pneumoni • Akut exacerbation av kronisk bronkit. • Komplicerade urinvägsinfektioner, även pyelonefrit. • Mjukdelsinfektioner: cellulit, erysipelas och sårinfektioner. • Intraabdominella infektioner. • Profylax mot infektion inför gastrointestinal (även esofageal), ortopedisk, kardiovaskulär och gynekologisk operation (även kejsarsnitt). Vid behandling och förebyggande av infektioner då det är mycket troligt att anaeroba organismer påträffas ska cefuroxim administreras tillsammans med ett lämpligt antianaerobt antibiotikum. Hänsyn ska tas till officiella riktlinjer om lämplig användning av antibakteriella medel.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = J01DC02</a></p><p><b>type</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/220000000060 220000000061}\">Marketing Authorisation</span></p><p><b>region</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000000002 100000000535}\">Kingdom of Sweden</span></p><p><b>status</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000072049 100000072099}\">Valid</span></p><p><b>statusDate</b>: 2005-06-23</p><p><b>holder</b>: <a href=\"Organization-LOC-100001098.html\">Organization Stragen Nordic A/S</a></p><h3>Cases</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Type</b></td><td><b>Date[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://ema.europa.eu/fhir/authorisationDateType dateOfFirstAuthorisation}\">First Authorisation</span></td><td>2005-06-23</td></tr></table></div>"
},
"identifier" : [
{
"system" : "http://ema.europa.eu/fhir/marketingAuthorizationNumber",
"value" : "21952"
}
],
"subject" : [
{
🔗 "reference" : "MedicinalProductDefinition/CefStragen-250mg-Powder-SE-IS-MPD"
}
],
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/220000000060",
"code" : "220000000061",
"display" : "Marketing Authorisation"
}
]
},
"region" : [
{
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000000002",
"code" : "100000000535",
"display" : "Kingdom of Sweden"
}
]
}
],
"status" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000072049",
"code" : "100000072099",
"display" : "Valid"
}
]
},
"statusDate" : "2005-06-23",
"holder" : {
🔗 "reference" : "Organization/LOC-100001098"
},
"case" : {
"type" : {
"coding" : [
{
"system" : "https://ema.europa.eu/fhir/authorisationDateType",
"code" : "dateOfFirstAuthorisation",
"display" : "First Authorisation"
}
]
},
"dateDateTime" : "2005-06-23"
}
}
},
{
"fullUrl" : "https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/PackagedProductDefinition/CefStragen-250mg-Powder-SE-IS-PPD",
"resource" : {
"resourceType" : "PackagedProductDefinition",
"id" : "CefStragen-250mg-Powder-SE-IS-PPD",
"meta" : {
"profile" : [
🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLPackagedProductDefinition"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"PackagedProductDefinition_CefStragen-250mg-Powder-SE-IS-PPD\"> </a><p class=\"res-header-id\"><b>Generated Narrative: PackagedProductDefinition CefStragen-250mg-Powder-SE-IS-PPD</b></p><a name=\"CefStragen-250mg-Powder-SE-IS-PPD\"> </a><a name=\"hcCefStragen-250mg-Powder-SE-IS-PPD\"> </a><a name=\"hcCefStragen-250mg-Powder-SE-IS-PPD-en-US\"> </a><p><b>identifier</b>: <code>http://ema.europa.eu/example/pcid</code>/?ngen-9?</p><p><b>packageFor</b>: <a href=\"MedicinalProductDefinition-CefStragen-250mg-Powder-SE-IS-MPD.html\">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100002835-00021952,http://ema.europa.eu/fhir/eurdId#615; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Powder for solution for injection; indication = Cefuroxim Stragen är avsett för behandling av nedanstående infektioner hos vuxna och barn, även nyfödda (från födelsen). • Samhällsförvärvad pneumoni • Akut exacerbation av kronisk bronkit. • Komplicerade urinvägsinfektioner, även pyelonefrit. • Mjukdelsinfektioner: cellulit, erysipelas och sårinfektioner. • Intraabdominella infektioner. • Profylax mot infektion inför gastrointestinal (även esofageal), ortopedisk, kardiovaskulär och gynekologisk operation (även kejsarsnitt). Vid behandling och förebyggande av infektioner då det är mycket troligt att anaeroba organismer påträffas ska cefuroxim administreras tillsammans med ett lämpligt antianaerobt antibiotikum. Hänsyn ska tas till officiella riktlinjer om lämplig användning av antibakteriella medel.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = J01DC02</a></p><p><b>containedItemQuantity</b>: 10 Vial<span style=\"background: LightGoldenRodYellow\"> (Details: 200000000014 code200000002158 = '200000002158')</span></p><p><b>description</b>: </p><div><p>Injektionsflaska, 10 st (10 x 250 mg)</p>\n</div><h3>MarketingStatuses</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Country</b></td><td><b>Status</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000000002 100000000535}\">Kingdom of Sweden</span></td><td><span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000072052 100000072083}\">Marketed</span></td></tr></table><blockquote><p><b>packaging</b></p><p><b>type</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000073346 100000073498}\">Box</span></p><p><b>quantity</b>: 1</p><p><b>material</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/200000003199 200000003529}\">Cardboard</span></p><blockquote><p><b>packaging</b></p></blockquote></blockquote></div>"
},
"identifier" : [
{
"system" : "http://ema.europa.eu/example/pcid"
}
],
"packageFor" : [
{
🔗 "reference" : "MedicinalProductDefinition/CefStragen-250mg-Powder-SE-IS-MPD"
}
],
"containedItemQuantity" : [
{
"value" : 10,
"unit" : "Vial",
"system" : "http://spor.ema.europa.eu/v1/lists/200000000014",
"code" : "200000002158"
}
],
"description" : "Injektionsflaska, 10 st (10 x 250 mg)",
"marketingStatus" : [
{
"country" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000000002",
"code" : "100000000535",
"display" : "Kingdom of Sweden"
}
]
},
"status" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000072052",
"code" : "100000072083",
"display" : "Marketed"
}
]
}
}
],
"packaging" : {
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000073346",
"code" : "100000073498",
"display" : "Box"
}
]
},
"quantity" : 1,
"material" : [
{
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/200000003199",
"code" : "200000003529",
"display" : "Cardboard"
}
]
}
],
"packaging" : [
{
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000073346",
"code" : "100000073563",
"display" : "Vial"
}
]
},
"quantity" : 10,
"material" : [
{
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/200000003199",
"code" : "200000003203",
"display" : "Glass"
}
]
}
],
"containedItem" : [
{
"item" : {
"reference" : {
🔗 "reference" : "ManufacturedItemDefinition/CefStragen-250mg-Powder-SE-IS-MID"
}
},
"amount" : {
"value" : 10,
"unit" : "Vial",
"system" : "http://spor.ema.europa.eu/v1/lists/200000000014",
"code" : "200000002158"
}
}
]
}
]
}
}
},
{
"fullUrl" : "https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/ManufacturedItemDefinition/CefStragen-250mg-Powder-SE-IS-MID",
"resource" : {
"resourceType" : "ManufacturedItemDefinition",
"id" : "CefStragen-250mg-Powder-SE-IS-MID",
"meta" : {
"profile" : [
🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLManufacturedItemDefinition"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"ManufacturedItemDefinition_CefStragen-250mg-Powder-SE-IS-MID\"> </a><p class=\"res-header-id\"><b>Generated Narrative: ManufacturedItemDefinition CefStragen-250mg-Powder-SE-IS-MID</b></p><a name=\"CefStragen-250mg-Powder-SE-IS-MID\"> </a><a name=\"hcCefStragen-250mg-Powder-SE-IS-MID\"> </a><a name=\"hcCefStragen-250mg-Powder-SE-IS-MID-en-US\"> </a><p><b>status</b>: Active</p><p><b>manufacturedDoseForm</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/200000000004 100000073866}\">Powder for solution for injection</span></p><p><b>unitOfPresentation</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/200000000014 200000002158}\">Vial</span></p></div>"
},
"status" : "active",
"manufacturedDoseForm" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/200000000004",
"code" : "100000073866",
"display" : "Powder for solution for injection"
}
]
},
"unitOfPresentation" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/200000000014",
"code" : "200000002158",
"display" : "Vial"
}
]
}
}
},
{
"fullUrl" : "https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/Ingredient/CefStragen-250mg-Powder-SE-IS-ING",
"resource" : {
"resourceType" : "Ingredient",
"id" : "CefStragen-250mg-Powder-SE-IS-ING",
"meta" : {
"profile" : [
🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLIngredient"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Ingredient_CefStragen-250mg-Powder-SE-IS-ING\"> </a><p class=\"res-header-id\"><b>Generated Narrative: Ingredient CefStragen-250mg-Powder-SE-IS-ING</b></p><a name=\"CefStragen-250mg-Powder-SE-IS-ING\"> </a><a name=\"hcCefStragen-250mg-Powder-SE-IS-ING\"> </a><a name=\"hcCefStragen-250mg-Powder-SE-IS-ING-en-US\"> </a><p><b>status</b>: Active</p><p><b>for</b>: </p><ul><li><a href=\"MedicinalProductDefinition-CefStragen-250mg-Powder-SE-IS-MPD.html\">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100002835-00021952,http://ema.europa.eu/fhir/eurdId#615; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Powder for solution for injection; indication = Cefuroxim Stragen är avsett för behandling av nedanstående infektioner hos vuxna och barn, även nyfödda (från födelsen). • Samhällsförvärvad pneumoni • Akut exacerbation av kronisk bronkit. • Komplicerade urinvägsinfektioner, även pyelonefrit. • Mjukdelsinfektioner: cellulit, erysipelas och sårinfektioner. • Intraabdominella infektioner. • Profylax mot infektion inför gastrointestinal (även esofageal), ortopedisk, kardiovaskulär och gynekologisk operation (även kejsarsnitt). Vid behandling och förebyggande av infektioner då det är mycket troligt att anaeroba organismer påträffas ska cefuroxim administreras tillsammans med ett lämpligt antianaerobt antibiotikum. Hänsyn ska tas till officiella riktlinjer om lämplig användning av antibakteriella medel.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = J01DC02</a></li><li><a href=\"ManufacturedItemDefinition-CefStragen-250mg-Powder-SE-IS-MID.html\">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Powder for solution for injection; unitOfPresentation = Vial</a></li><li><a href=\"AdministrableProductDefinition-CefStragen-250mg-Powder-SE-IS-APD.html\">AdministrableProductDefinition: status = active; administrableDoseForm = Solution for injection</a></li></ul><p><b>role</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000072050 100000072072}\">Active</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://spor.azure-api.net/sms/api/v2/SubstanceDefinition 100000091436}\">cefuroxime sodium</span></td></tr></table><blockquote><p><b>strength</b></p><p><b>concentration</b>: 263 milligram(s)<span style=\"background: LightGoldenRodYellow\"> (Details: 100000110633 code100000110655 = '100000110655')</span>/1 unit(s)<span style=\"background: LightGoldenRodYellow\"> (Details: 100000110633 code100000110756 = '100000110756')</span></p><blockquote><p><b>referenceStrength</b></p><h3>Substances</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://spor.azure-api.net/sms/api/v2/SubstanceDefinition 100000092667}\">cefuroxime</span></td></tr></table><p><b>strength</b>: 250 milligram(s)<span style=\"background: LightGoldenRodYellow\"> (Details: 100000110633 code100000110655 = '100000110655')</span>/1 unit(s)<span style=\"background: LightGoldenRodYellow\"> (Details: 100000110633 code100000110756 = '100000110756')</span></p></blockquote></blockquote></blockquote></div>"
},
"status" : "active",
"for" : [
{
🔗 "reference" : "MedicinalProductDefinition/CefStragen-250mg-Powder-SE-IS-MPD"
},
{
🔗 "reference" : "ManufacturedItemDefinition/CefStragen-250mg-Powder-SE-IS-MID"
},
{
🔗 "reference" : "AdministrableProductDefinition/CefStragen-250mg-Powder-SE-IS-APD"
}
],
"role" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000072050",
"code" : "100000072072",
"display" : "Active"
}
]
},
"substance" : {
"code" : {
"concept" : {
"coding" : [
{
"system" : "https://spor.azure-api.net/sms/api/v2/SubstanceDefinition",
"code" : "100000091436",
"display" : "cefuroxime sodium"
}
]
}
},
"strength" : [
{
"concentrationRatio" : {
"numerator" : {
"value" : 263,
"unit" : "milligram(s)",
"system" : "http://spor.ema.europa.eu/v1/lists/100000110633",
"code" : "100000110655"
},
"denominator" : {
"value" : 1,
"unit" : "unit(s)",
"system" : "http://spor.ema.europa.eu/v1/lists/100000110633",
"code" : "100000110756"
}
},
"referenceStrength" : [
{
"substance" : {
"concept" : {
"coding" : [
{
"system" : "https://spor.azure-api.net/sms/api/v2/SubstanceDefinition",
"code" : "100000092667",
"display" : "cefuroxime"
}
]
}
},
"strengthRatio" : {
"numerator" : {
"value" : 250,
"unit" : "milligram(s)",
"system" : "http://spor.ema.europa.eu/v1/lists/100000110633",
"code" : "100000110655"
},
"denominator" : {
"value" : 1,
"unit" : "unit(s)",
"system" : "http://spor.ema.europa.eu/v1/lists/100000110633",
"code" : "100000110756"
}
}
}
]
}
]
}
}
},
{
"fullUrl" : "https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/AdministrableProductDefinition/CefStragen-250mg-Powder-SE-IS-APD",
"resource" : {
"resourceType" : "AdministrableProductDefinition",
"id" : "CefStragen-250mg-Powder-SE-IS-APD",
"meta" : {
"profile" : [
🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLAdministrableProductDefinition"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"AdministrableProductDefinition_CefStragen-250mg-Powder-SE-IS-APD\"> </a><p class=\"res-header-id\"><b>Generated Narrative: AdministrableProductDefinition CefStragen-250mg-Powder-SE-IS-APD</b></p><a name=\"CefStragen-250mg-Powder-SE-IS-APD\"> </a><a name=\"hcCefStragen-250mg-Powder-SE-IS-APD\"> </a><a name=\"hcCefStragen-250mg-Powder-SE-IS-APD-en-US\"> </a><p><b>status</b>: Active</p><p><b>formOf</b>: <a href=\"MedicinalProductDefinition-CefStragen-250mg-Powder-SE-IS-MPD.html\">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100002835-00021952,http://ema.europa.eu/fhir/eurdId#615; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Powder for solution for injection; indication = Cefuroxim Stragen är avsett för behandling av nedanstående infektioner hos vuxna och barn, även nyfödda (från födelsen). • Samhällsförvärvad pneumoni • Akut exacerbation av kronisk bronkit. • Komplicerade urinvägsinfektioner, även pyelonefrit. • Mjukdelsinfektioner: cellulit, erysipelas och sårinfektioner. • Intraabdominella infektioner. • Profylax mot infektion inför gastrointestinal (även esofageal), ortopedisk, kardiovaskulär och gynekologisk operation (även kejsarsnitt). Vid behandling och förebyggande av infektioner då det är mycket troligt att anaeroba organismer påträffas ska cefuroxim administreras tillsammans med ett lämpligt antianaerobt antibiotikum. Hänsyn ska tas till officiella riktlinjer om lämplig användning av antibakteriella medel.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = J01DC02</a></p><p><b>administrableDoseForm</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/200000000004 100000073863}\">Solution for injection</span></p><p><b>producedFrom</b>: <a href=\"ManufacturedItemDefinition-CefStragen-250mg-Powder-SE-IS-MID.html\">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Powder for solution for injection; unitOfPresentation = Vial</a></p><h3>RouteOfAdministrations</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000073345 100000073600}, {https://spor.ema.europa.eu/v1/lists/100000073345 100000073611}\">Intramuscular use</span></td></tr></table></div>"
},
"status" : "active",
"formOf" : [
{
🔗 "reference" : "MedicinalProductDefinition/CefStragen-250mg-Powder-SE-IS-MPD"
}
],
"administrableDoseForm" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/200000000004",
"code" : "100000073863",
"display" : "Solution for injection"
}
]
},
"producedFrom" : [
{
🔗 "reference" : "ManufacturedItemDefinition/CefStragen-250mg-Powder-SE-IS-MID"
}
],
"routeOfAdministration" : [
{
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000073345",
"code" : "100000073600",
"display" : "Intramuscular use"
},
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000073345",
"code" : "100000073611",
"display" : "Intravenous use"
}
]
}
}
]
}
},
{
"fullUrl" : "https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/Organization/LOC-100001098",
"resource" : {
"resourceType" : "Organization",
"id" : "LOC-100001098",
"meta" : {
"profile" : [
🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLOrganization"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Organization_LOC-100001098\"> </a><p class=\"res-header-id\"><b>Generated Narrative: Organization LOC-100001098</b></p><a name=\"LOC-100001098\"> </a><a name=\"hcLOC-100001098\"> </a><a name=\"hcLOC-100001098-en-US\"> </a><p><b>identifier</b>: <code>https://spor.ema.europa.eu/v1/locations</code>/LOC-100001098</p><p><b>name</b>: Stragen Nordic A/S</p></div>"
},
"identifier" : [
{
"system" : "https://spor.ema.europa.eu/v1/locations",
"value" : "LOC-100001098"
}
],
"name" : "Stragen Nordic A/S"
}
}
]
}
IG © 2022+ UNICOM. Package hl7.eu.fhir.ufis-swe-unicom#0.1.0 based on FHIR 5.0.0. Generated 2024-06-28
Links: Table of Contents |
QA Report
The UNICOM Innovation Action has received funding from the European Union's Horizon 2020
research and innovation programme under grant agreement No. 875299.
